Apex Clinical Research Center

APEX CLINICAL RESEARCH CENTER PROVIDES

Access to cutting edge clinical trials so that our patients can make a difference and can be a part of advancing the field of dermatology.

WHAT CONDITIONS DO WE WORK WITH?

At Apex Clinical Research Center, we have experience in:

Atopic Dermatitis (Eczema) for adults and children
Psoriasis for adults and children
Hidradenitis Suppurativa
Gorlin Syndrome
Pyoderma Gangrenosum
Lichen Planus
Vitiligo
Prurigo Nodularis
Alopecia Areata
Palmoplantar and Genital
Psoriasis
And More...

Pediatric Atopic Dermatitis (age 2-12)

Status: RECRUITING

Pediatric Atopic Dermatitis (age 2-12)

Non-steroid cream applied once daily to areas of eczema or placebo (randomized)

Inclusion criteria:

-Parent/guardian informed consent

-Male or female patient age 2-12 with clinical diagnosis of Atopic Dermatitis (eczema)

-diagnosis of at least 6 months

-Up to 7 in-person visits over the course of 8 weeks

-Stipend provided to parent/guardian

If you are interested in participating, please submit study form below and our research team will contact you. You may also email research@apexskin.com or call 440-443-0440 Ext 10015

Adult Atopic Dermatitis (Oral medication)

Status: RECRUITING

Oral PDE4 inhibitor or placebo (randomized)

Inclusion criteria:

-Informed consent

-Male and female subjects age 18 and older

-diagnosis of moderate-severe Atopic Dermatitis (eczema) for at least 1 year

-Cannot have history of Hep B, Hep C, HIV, or cancer

Up to 9 visits over the course of 6 months

Stipend provided to patient

Adult Plaque Psoriasis (Injectable)

Biosimilar biologic to Stelara vs. Stelara injection (randomized)

Inclusion criteria:

-Informed consent

-Adults age 18-80

-Diagnosis of moderate-severe plaque psoriasis for at least 6 months and is a candidate for systemic therapy

-Cannot have history of Hep B, Hep C, HIV, TB, or cancer

Up to 9 visits over the course of 7 months

Stipend provided to patient

If you are interested in participating, please submit study form below and our research team will contact you. You may also email research@apexskin.com or call 440-443-0440 Ext 10015.

Adult Neurofibromatosis Type 1/Cutaneous Neurofibromas (Topical gel)

Status: RECRUITING

Topical MEK-inhibitor or placebo (randomized)

Inclusion criteria:

-Informed consent

-Adult patients (age 18 and older) with clinical diagnosis of NF1

-Patient has at least 10 clinically diagnosed cutaneous neurofibromas with 2 on the face ad 8 on the upper body

Up to 9 visits over the course of about 7 months

Stipend provided to patient

You may also email research@apexskin.com or call 440-443-0440 Ext 10015.

Pediatric Psoriasis

Status: RECRUITING

Inclusion criteria:

–Informed consent
–Age > 18 years of age
–Psoriasis criteria
–Patient will follow up with treating physician

You may also email research@apexskin.com or call 440-443-0440 Ext 10015.

Current Studies

Our portfolio includes a variety of marketed drugs such as Opzelura, Skyrizi, Otezla, Tremfya,as well as novel investigational drugs in various forms including topicals, oral medications, injectables, and IV therapies. We have conducted phase 1 through 4 trials for conditions such as psoriasis, eczema, hidradenitis suppurativa, vitiligo, lichen planus, alopecia, and more!

THE RESEARCH TEAM

We strive to leave no patient behind.

WHAT SETS US APART

Study Startup

Contract / Budget Timelines

Fast-track
Reviewed within 1 week

Accelerated Start-Up Timeline

Regulatory edits within 1 week
SSU done during budget edits

Recruitment / Retention

14 clinics
>20,000 patients per month
Developed database
In-house marketing
Low s/f rate (<11%)
Prescreening team
Complimentary prescreening visits with a Sub-Investigator
Spanish speaking staff

Community Engagement

Pediatric providers
RA
Community events
Informational dinners
Podcast appearances

Quality Assurance

Dedicated QA/Data entry staff
48-hour data entry/query resolution target
Quarterly in-house mock audits

Experienced Site Staff

CCRC
GCP certified
IATTA certified

Members of SCRS, ACRP and SOCRA

Current Studies

Our portfolio includes a variety of marketed drugs such as Opzelura, Skyrizi, Otezla, Tremfya,as well as novel investigational drugs in various forms including topicals, oral medications, injectables, and IV therapies. We have conducted phase 1 through 4 trials for conditions such as psoriasis, eczema, hidradenitis suppurativa, vitiligo, lichen planus, alopecia, and more!

What Is Clinical Research?

All pharmaceutical medicines require a lengthy process of review before being approved by the FDA (U.S. Food and Drug Administration) for human use. This process can take many years as studies progress through the “phases”. As opposed to “pre-clinical” The research is considered “clinical” once humans are included. Apex Dermatology’s Clinical Research Center partners with pharmaceutical companies to study the effectiveness and safety of newer dermatologic therapies. We aim to work with participants to advance medical treatments!

BLOG

Hidradenitis Suppurativa: Advancing
Hope throughClinical Trials

Hidradenitis suppurativa (HS) is a chronic, autoimmune inflammatory disorder causing painful, deep, pea-sized lumps and nodules under the skin, particularly in sweaty areas like the armpits

Keep Reading

CONTACT US

BOOK YOUR VISIT TODAY

Contact Us

Phone : 440-979-2739
Email : research@apexskin.com

Locations

Our main research center is inside our new, state-of-the art, medical building in Mayfield Heights, OH.
We will have approximately 2,000 square feet of space dedicated to research

29111 Cedar Road Mayfield Heights, OH 44214

Apex Clinical Research is committed to bringing dermatological clinical trials to NE Ohio and plan to expand to additional clinics soon.